Cyclophosphamide augments the efficacy of in situ vaccination in a mouse melanoma model is a research paper published in Frontiers in Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5U01CA233102-04
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
National Institutes of Health
Grant: 5P50DE026787-02
Head and Neck Cancer SPORE at the University of Wisconsin
National Institutes of Health
Grant: 1R35CA197078-01
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
National Institutes of Health
Grant: 5P01CA250972-02
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
National Institutes of Health
Grant: 5DP5OD024576-02
Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination
National Institutes of Health
Grant: 3U54CA232568-01S4
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
Fields of Study
Keywords
Sustainable Development Goals